Core Laboratories Inc. (CLB) Market Cap & Valuation Ratios
Core Laboratories Inc. (CLB) has a market cap of $454.7M, a trailing P/E of 19.1 and a price-to-sales ratio of 0.9, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLBCore Laboratories Inc.Follow CLB — free
—
Price chart with a free account
- Market cap
- 454.7M
- P/E TTM
- 19.1
- Dividend yield
- 0.4%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Peers
oil & gas equipment & services · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| CLB | 0.5 | 19.1 | 1.1 | 8.7 | 2.4% | +0.3% | 9% | 9% |
| AESI | 1.1 | — | 1.8 | 16.1 | — | -8% | -8% | -5% |
| HOS | 1.0 | 26.3 | 0.5 | 2.7 | 22.5% | +2% | 6% | 3% |
| FET | 1.0 | — | 1.3 | 15.8 | 5.4% | +4% | 5% | 7% |
| PUMP | 0.9 | — | 0.8 | 5.8 | -2.4% | -15% | -1.0% | -1% |
| HMH | 0.8 | — | — | — | — | — | -3% | — |
| ACDC | 0.7 | — | 1.0 | 13.7 | -8.2% | -16% | -15% | -15% |
| OIS | 0.5 | — | 0.8 | — | 10.4% | -3% | -14% | -14% |
| NGS | 0.4 | 19.2 | 3.8 | 9.0 | -7.8% | +15% | 22% | 6% |
| RNGR | 0.3 | 24.5 | 0.6 | 4.5 | 6.8% | +6% | 4% | 6% |
| NOA | 0.3 | — | — | — | — | +10% | 9% | 5% |
| Median of these 10 | 24.5 | 0.9 | 9.0 | 5.4% | +2% | 1% | 3% |
P/E 19.1 vs. a peer median of 24.5; EV/Sales 1.1 vs. 0.9. CLB's own P/E sits at the 19th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesAESI and FET and PUMP and HMH and ACDC and OIS and NOA have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Core Laboratories Inc. — questions
- What is Core Laboratories Inc.'s market cap?
- $454.7M.
- What is Core Laboratories Inc.'s P/E ratio?
- 19.1 on trailing twelve-month earnings to 2026-06-30.
- What is Core Laboratories Inc.'s price-to-sales ratio?
- 0.9.
Every figure on this page comes from Core Laboratories Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.